|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel显示文摘 | Penson RT Kronish K Duan Z | 2000 | Int J Gynecol Cancer2000，10，1： | 1 |
| 2 | Phase II trial of the oral PARP inhibitor olaparib (AZD2281) in BRCA-deficient advanced ovarian cancer 显示文摘 | Audeh MW Penson RT Friedlander M | 2009 | Journal of Clinical Oncology2009，27，15： | 1 |
| 3 | Cytokines IL- 1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxe 显示文摘 | Penson RT Kronish K Duan Z | 2000 | Int J Gynecol Cancer2000，10，1： | 1 |
| 4 | Discovery of differentially expressed genes associated with paclitaxel resistance using eDNA array technology: analysis of interleukin (IL)6, IL-8, and monocyte chemotactie protein 1 in the paclitaxel-resistant phenotype显示文摘 | Duan Z Feller A J Penson RT | 1999 | Clin Cancer Res1999，5，11： | 1 |
| 5 | Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte ehemotactic protein 1 in the paclitaxel-resistant phenotype显示文摘 | Duan Z Feller AJ Penson RT | 1999 | Clin Cancer Res1999，5，11： | 1 |
| 6 | Cytokines IL-lbeta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel 显示文摘 | Penson RT Kronish K Duan Z | 2000 | Int J Gynecol Cancer2000，10，1： | 1 |
| 7 | Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells显示文摘 | Duan Z Lamendola DE Penson RT | 2002 | Cytokine2002，17，5： | 1 |
| 8 | Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-20S human osteosarcoma cells显示文摘 | Duan Z Lamendola DE Penson RT | 2002 | Cytokine2002，17，5： | 1 |
| 9 | Cone damage in patients receiving higf-dose irofulven treatment显示文摘 | Lee MS Gupta N Penson RT | 2005 | Arch Ophthalmol2005，123，1： | 1 |
| 10 | Panniculitis associated with dermatomyositis and recurrent ovarian cancer显示文摘 | Girouard SD Velez NF Penson RT | 2012 | Arch Dermatol2012，148，6： | 1 |
| 11 | A phase II trial of Suni- tinib malate in recurrent and refractory ovarian,fallopian tube and peritoneal carcinoma显示文摘 | Campos SM Penson RT Matulonis U | 2012 | Gynecol Oncol2012，9，： | 1 |
| 12 | Phase Ⅱ study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first - line chemotherapy for advanced Mtilleriantumors 显示文摘 | Penson RT Dizon DS Cannistra SA | 2010 | J Clin Oncol2010，28，1： | 1 |
| 13 | Potential benefit of Sunitinib in recurrent and refractory ovarian clear cell adenncarcinoma 显示文摘 | Rauh-Hain JA Penson RT | 2008 | Int J Gynecol Cancer2008，18，5： | 1 |
| 14 | Phase II study of bevacizumab in patients with platinum - resistant ovarian cancer or peritoneal serous caneer 显示文摘 | Cannistra SA Matulonis UA Penson RT | 2007 | J Clin On- eol2007，25，33： | 1 |
| 15 | Oral poly (ADP- ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian Cancer: a proof-of-concept trial显示文摘 | Audeh MW Carmichael J Penson RT | 2010 | Lancet2010，376，9737： | 1 |
| 16 | Help me help you: support groups in cancer therapy 显示文摘 | Penson RT Talsania SH Chabner BA | 2004 | Oncologist2004，9，2： | 1 |
| 17 | Phase II study ofbevacizumab in patients with platinum-resistant ovarian cancer orperitoneal serous cancer显示文摘 | Cannistra SA Matulonis UA Penson RT | 2007 | J Clin Oncol2007，25，33： | 1 |
| 18 | Phase II study of car-boplatin,paclitaxel,and bevacizumab with maintenance beva-cizumab as first-line chemotherapy for advanced mullerian tumors显示文摘 | Penson RT Dizon DS Cannistra SA | 2010 | J Clin Oncol2010，28，1： | 1 |
| 19 | Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mu- tations and recurrent ovarian cancer:a proof-of-concept trial 显示文摘 | Audeh MW Carmichael J Penson RT | 2010 | Lancet2010，376，9737： | 1 |
| 20 | Cytokines IL-lbeta, IL- 2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment withpaclitaxel显示文摘 | Penson RT Kronish K Duan Z | 2000 | Int J Gynecol Cancer2000，10，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员